Kwality Pharmaceuticals Limited has announced the appointment of Mr. PreetMohinder Singh Bedi as an Additional Independent Director on its Board. This appointment is aimed at strengthening the company’s governance framework and leveraging Mr. Bedi’s professional expertise to guide the firm’s strategic growth. As an Independent Director, he will play a crucial role in ensuring board transparency and protecting the interests of minority shareholders as the company continues to expand its footprint in the pharmaceutical manufacturing and export sectors.
Trending
- Pernod Ricard India Appoints Sonia Arora as Director of Consumer Insights
- PM Narendra Modi Becomes India’s Longest-Serving Head of Government
- Whole-time Director Indirakumar Resigns from Indrayani Biotech Board
- Secretary Debashree Mukherjee Assigned Additional Charge as Chairperson, NCVET
- Chief Growth Officer Amber Faulkner Joins Droga5 London
- Minister Laljit Singh Bhullar Resigns from Punjab Cabinet Following Official’s Suicide
- Sagarsoft (India) Appoints Finance Veteran Kanakadhara Srinivasan to its Board
- IAS Pramod Kumar Meherda Assigned Additional Charge as CEO, NRAA

